Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 15/03/2024
In
Objective
To achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects.
AIC sector
Management group
Syncona Investment Management Limited
Company website
Launch date
26/10/2012
March
Domicile
Guernsey
Fund manager
Chris Hollowood
Dividend frequency
Annually
Wind-up provisions
The Company has an unlimited life.
Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
---|---|---|---|---|---|---|---|---|
857.47 | 1,235.66 | 130.60 | 188.20 | -30.61 | 0 | 0.00 | Jul | 0.88 (31/03/2023) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
Return type | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Syncona | Share price total return | -11.2 | -50.2 | -46.4 | 15.8 |
Biotechnology & Healthcare AIC sector | Share price total return | 2.9 | -22.2 | 1.9 | 112.2 |
Scroll
Share structure
Number of shares
656,565,586
15,241,080
Traded volumes (number of shares)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 2,181,998 | 19,248,157 | 186,708,066 | 889,411,000 |
Average | N/A | 916,579 | 737,977 | 704,763 |
Scroll
Traded values (m)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 2.85 | 24.28 | 243.36 | 1,745.33 |
Average | N/A | 1.16 | 0.96 | 1.38 |
Scroll
Trading details
Top holdings
Data as at : 30/09/2023
Investment | % of total assets |
---|---|
Quell Therapeutics Limited | 7.3 |
SwanBio Therapeutics Limited | 6.4 |
Beacon Therapeutics Holdings Limited1 | 6.2 |
Anaveon AG | 5.4 |
Autolus Therapeutics plc | 5.3 |
OMass Therapeutics Limited | 3.6 |
Resolution Therapeutics Limited | 3.2 |
Purespring Therapeutics Limited | 2.9 |
Clade Therapeutics Inc | 2.0 |
Cambridge Epigenetix Limited | 1.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.